fda glp-1 compounding enforcement october 2025 Ozempic's patent problem: how Novo Nordisk lost control of a blockbuster drug. 💉 Demand for weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Despite FDA crackdown, unapproved GLP-1s

A new study published in Cell Metabolism found that semaglutide (a GLP-1) may help alleviate osteoarthritis related inflammation and tissue damage including cartilage destruction, osteophyte formation and pain sensitivity, independent of weight loss

Do the molecular properties of GLP-1 drugs suggest they reach breast milk

A medically supervised weight-loss program offers a more thoughtful way to approach the process

The pancreas continues to produce amylase, lipase, and proteases normally

Clinical trials have demonstrated significant reductions in hemoglobin A1c levels (approximately 1.52.0% from baseline) and substantial weight loss (averaging 1015% of body weight with higher doses)

When this area gets activated, your bodys natural response is to feel sick or sometimes to be sick